RMD

ResMed
D

RMD

239.700
USD
2.61
(1.10%)
مغلق
حجم التداول
17,087
الربح لكل سهم
9
العائد الربحي
0.84
P/E
32
حجم السوق
35,186,940,316
أصول ذات صلة
    ABT
    ABT
    -0.420
    (-0.37%)
    113.490 USD
    B
    BAX
    0.020
    (0.06%)
    30.970 USD
    BDX
    BDX
    1.040
    (0.44%)
    237.340 USD
    BSX
    BSX
    0.463
    (0.47%)
    98.643 USD
    EW
    EW
    -0.080
    (-0.11%)
    69.790 USD
    JNJ
    JNJ
    -0.740
    (-0.50%)
    147.060 USD
    MDT
    MDT
    0.920
    (1.06%)
    88.090 USD
    P
    PRGO
    -0.010
    (-0.04%)
    23.860 USD
    SYK
    SYK
    1.63
    (0.43%)
    383.42 USD
    ZBH
    ZBH
    0.630
    (0.58%)
    109.560 USD
    المزيد
الأخبار المقالات

العنوان: ResMed

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.